Our goal for FY2020 was to achieve the following two specific aims:
1.AIM 1: Evaluating molecular determinants in human aged hematopoietic stem and progenitor cells (HSPCs)
2.AIM 2: Developing an In-vitro 3D bone marrow microenvironment model
To achieve AIM 1, we have processed three bone marrow derived HSPCs samples that were taken from aged donors (>65 years) and two samples from young donors (<25 years) using single cell RNA sequencing. Results obtained through computational analyses revealed an increase in HSC subsets in aged HSPCs and a marked decrease in lymphoid progenitors compared to younger counterparts. Gene set enrichment analyses showed that aged HSPC subsets have a profound activation of pro-inflammatory gene categories and defective DNA repair capacity and cell proliferation compared to young HSPCs. We discovered that surprisingly senescence-related gene categories were not upregulated compared to younger counterparts, at least in steady state. We will continue this study in the next fiscal year to complete experiments in liquid culture and obtain a comprehensive understanding of the scenance mechanism.
For AIM 2, we have mainly two parts. The first part relates to the creation of a 3D microfluidic bone marrow on a chip. We have developed a new 3D microfluidic device and optimized the conditions to recreate a 3D model with functional and perfusable vasculature. Since the bone marrow comprises many cell types and has a unique sinusoidal blood supply that gives rise to distinct microenvironments or niches, we started by developing a robust multicellular model of perfusable vasculature. We used cancer cell lines as a model for HSPC (CD34+) and bone marrow stromal cell niche to achieve this milestone. We embedded the created cell aggerates into the new microfluidic device together with an extracellular matrix (ECM) composed of fibrinogen, thrombin, and collagen.
To create a perfusable and functional vasculature network surrounding the tumor aggregate, the tumor is seeded in the microfluidic device together with Human Umbilical Vein Endothelial Cells (HUVEC) and Human Lung Fibroblasts (NHLF). Within a week, HUVEC and NHLF self-organize into a perfusable microvasculature system. This 3D in vitro vascularized model will be used to study bone marrow niche-vasculature interactions in the next fiscal year.
The second part of AIM 2 relates to the design and development of a robotic automation system to handle the 3D microfluidic model. We are creating a custom-designed automated liquid and cell handling robotic system, which comprises of a robotic manipulator for cell and plate handling, a conveyor for transportation to and from the robot workstation, an incubator for circulation of media, and a storage compartment.
The robotic manipulator has been fabricated using 3D printed and machined parts, and a custom-design control system was developed. We updated the Computer-Aided Design (CAD) of the robotic automation system from last year and realized the robot submodules. We developed a kinematic model of the proposed robot arm and developed its mathematical model.
Forward kinematics of robot manipulator has been developed for determining the position and orientation of a robot gripper with respect to a reference coordinate system (O), given the joint variables (θ_i) and the link lenghths (l_i). A PID controller has been implemented to control the robot’s gripper and orientation of the robotic arm for autonomous and operator-controlled functions.
In addition, necessary components such as sensors, motors, material for fabrication, motor controllers, acrcylic sheets for incubator, conveyor belts, etc., have been purchased. A first prototype of the robotic arm is being assembled at the moment for pilot testing.
In the future, we plan to perform the validation of the developed robotic system and use it with the 3D microenvironment devices developed by Dr. Andrea (Co-PI) from Singapore.